» Articles » PMID: 20874503

Quantifying Interhospital Patient Sharing As a Mechanism for Infectious Disease Spread

Abstract

Background: Assessments of infectious disease spread in hospitals seldom account for interfacility patient sharing. This is particularly important for pathogens with prolonged incubation periods or carrier states.

Methods: We quantified patient sharing among all 32 hospitals in Orange County (OC), California, using hospital discharge data. Same-day transfers between hospitals were considered "direct" transfers, and events in which patients were shared between hospitals after an intervening stay at home or elsewhere were considered "indirect" patient-sharing events. We assessed the frequency of readmissions to another OC hospital within various time points from discharge and examined interhospital sharing of patients with Clostridium difficile infection.

Results: In 2005, OC hospitals had 319,918 admissions. Twenty-nine percent of patients were admitted at least twice, with a median interval between discharge and readmission of 53 days. Of the patients with 2 or more admissions, 75% were admitted to more than 1 hospital. Ninety-four percent of interhospital patient sharing occurred indirectly. When we used 10 shared patients as a measure of potential interhospital exposure, 6 (19%) of 32 hospitals "exposed" more than 50% of all OC hospitals within 6 months, and 17 (53%) exposed more than 50% within 12 months. Hospitals shared 1 or more patient with a median of 28 other hospitals. When we evaluated patients with C. difficile infection, 25% were readmitted within 12 weeks; 41% were readmitted to different hospitals, and less than 30% of these readmissions were direct transfers.

Conclusions: In a large metropolitan county, interhospital patient sharing was a potential avenue for transmission of infectious agents. Indirect sharing with an intervening stay at home or elsewhere composed the bulk of potential exposures and occurred unbeknownst to hospitals.

Citing Articles

Carbapenemase-producing enterobacterales colonisation status does not lead to more frequent admissions: a linked patient study.

Lydeamore M, Donker T, Wu D, Gorrie C, Turner A, Easton M Antimicrob Resist Infect Control. 2024; 13(1):82.

PMID: 39075552 PMC: 11287836. DOI: 10.1186/s13756-024-01437-x.


Regional patient transfer patterns matter for the spread of hospital-acquired pathogens.

Xia H, Horn J, Piotrowska M, Sakowski K, Karch A, Kretzschmar M Sci Rep. 2024; 14(1):929.

PMID: 38195669 PMC: 10776674. DOI: 10.1038/s41598-023-50873-z.


Transmission of drug-resistant bacteria in a hospital-community model stratified by patient risk.

Brachaczek P, Lonc A, Kretzschmar M, Mikolajczyk R, Horn J, Karch A Sci Rep. 2023; 13(1):18593.

PMID: 37903799 PMC: 10616222. DOI: 10.1038/s41598-023-45248-3.


Antibiotic Susceptibility Patterns for Carbapenem-Resistant Enterobacteriaceae.

Armin S, Fallah F, Karimi A, Karbasiyan F, Alebouyeh M, Tabatabaei S Int J Microbiol. 2023; 2023:8920977.

PMID: 36860272 PMC: 9970715. DOI: 10.1155/2023/8920977.


Clinical epidemiology of carbapenem-resistant Enterobacterales in the Greater Houston region of Texas: a 6-year trend and surveillance analysis.

Tadese B, Darkoh C, DeSantis S, Mgbere O, Fujimoto K J Glob Antimicrob Resist. 2022; 30:222-227.

PMID: 35764216 PMC: 9486688. DOI: 10.1016/j.jgar.2022.06.019.


References
1.
Jarvis W, Schlosser J, Jarvis A, Chinn R . National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control. 2009; 37(4):263-70. DOI: 10.1016/j.ajic.2009.01.001. View

2.
Baker S, Brecher S, Robillard E, Strymish J, Lawler E, Gupta K . Extranasal methicillin-resistant Staphylococcus aureus colonization at admission to an acute care Veterans Affairs hospital. Infect Control Hosp Epidemiol. 2009; 31(1):42-6. DOI: 10.1086/649222. View

3.
Bootsma M, Diekmann O, Bonten M . Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci U S A. 2006; 103(14):5620-5. PMC: 1459403. DOI: 10.1073/pnas.0510077103. View

4.
Jarvis W, Schlosser J, Chinn R, Tweeten S, Jackson M . National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006. Am J Infect Control. 2007; 35(10):631-7. DOI: 10.1016/j.ajic.2007.10.009. View

5.
Jeyaratnam D, Whitty C, Phillips K, Liu D, Orezzi C, Ajoku U . Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ. 2008; 336(7650):927-30. PMC: 2335244. DOI: 10.1136/bmj.39525.579063.BE. View